Placeholder Banner

IPO Update Feb 4th, 2010

February 4, 2010

13 Biotechs have filed to go public:

*BG Medicine (01/29/10), "Molecular Diagnostics", $86M sought
Codexis (12/28/09), “Emerging Biotech”, $100M sought  (CDXS)
Rules-Based Medicine (12/23/09), “Diagnostics”, $90M sought (RULE)
Tengion (12/24/09), “Emerging Biotech”, $40.3M sought (TNGN)
Aveo Pharmaceuticals (12/16/09), “Emerging Biotech”,$86.3M sought
CorMedix Inc. (11/25/09), “Emerging Biotech”, $18M sought
Trius Therapeutics (11/09/09),”Emerging Biotech”, $86.3M sought (TSRX)
Alimera (11/01/09), “Emerging Biotech”, $80M sought (ALIM)
Aldagen (10/28/09), “Emerging Biotech”, $80.5M sought (ALDH)
Anthera (09/15/09), “Emerging Biotech”, $70M sought (ANTH)
Prometheus (8/11/09), “Spec Pharma”, undisclosed amount
*Med Biogene (12/29/09) “Diagnostic”,  US IPO $24.25M sought, (MBGI) (Canadian)
*AB Science
(02/03/10) “Emerging Biotech”, $70M sought (France)

4 Recent US IPOs, 7 INTL IPOs:

*Ironwood (02/03/10), “Emerging Biotech”, $188M IPO (IRWD)
Omeros (10/08/09), “Emerging Biotech”, $68.2M IPO (OMER)
Talecris Biotherapeutics (10/01/09), “Spec Pharma”, $855M IPO (TLCR)
Cumberland (08/12/09), “Spec Pharma”, $85M IPO (CPIX)

Cbio Ltd (12/16/09), “Emerging Biotech”, $28M (CBZ-ASX) (Australia)
Human Stem Cell Institute (12/16/09) “Emerging Biotech”, $5M (HSCI) (Russia)
Movetis (12/7/09), “JNJ spin out, marketed drug”, $150M ( (Belgium)
China Nuokang Bio-Pharmaceutical (12/09/09), “Spec Pharma”, $40.7M  (NKBP) (China)
D. Western Therapeutics (10/03/09), “Venture Biotech”, $9.7M (JASDAQ: 4576) (Japan)
CanBas Co. Ltd. (9/17/09), “Emerging biotech”, $14.8M (Tokyo:4575) (Japan)
D-Pharm (8/17/09) “Spec Pharma”, $7.4M (TASE:DPRM) (Israel)

*new update